Incyte Corporation (INCY) stock analysis

In our weekly check, Incyte Corporation is graded A (A to F). Of 20 checks on debt, profit, cash flow and trend: 17 pass, warnings: 3, red flags: 0.

Sector: Healthcare · Biotechnology

Strengths

• Low debt
• Easily covers interest
• Profits backed by cash
• High margins
• Strong free cash flow

Warning signs

• Margins falling
• Gross margin falling

Next earnings report: 2026-10-27

Similar companies

INSM · ALNY · ONC · HALO · RVMDW · TXG

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks graded D or F lost a third of their value 2-3 times as often as those graded A or B.

Updated 2026-10-03

Open the full analysis